![IJMS | Free Full-Text | Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment IJMS | Free Full-Text | Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment](https://www.mdpi.com/ijms/ijms-20-00706/article_deploy/html/images/ijms-20-00706-g003.png)
IJMS | Free Full-Text | Long-Term Efficacy and Safety of Pemafibrate, a Novel Selective Peroxisome Proliferator-Activated Receptor-α Modulator (SPPARMα), in Dyslipidemic Patients with Renal Impairment
![Table 4 from Prediction of Polymer Glass Transition Temperatures Using a General Quantitative Structure-Property Relationship Treatment | Semantic Scholar Table 4 from Prediction of Polymer Glass Transition Temperatures Using a General Quantitative Structure-Property Relationship Treatment | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b8320157c1baf673fd25ce1b66d44f647536f2a9/4-Table4-1.png)
Table 4 from Prediction of Polymer Glass Transition Temperatures Using a General Quantitative Structure-Property Relationship Treatment | Semantic Scholar
![Abstract 405: Utility of Very Low-density Lipoprotein Cholesterol to Total Triglyceride Ratio (VLDL-C/TG) and Non-VLDL TG to Quantify Remnant Lipoprotein Cholesterol (RLP-C): The Very Large Database of Lipids Study 7C | Arteriosclerosis, Abstract 405: Utility of Very Low-density Lipoprotein Cholesterol to Total Triglyceride Ratio (VLDL-C/TG) and Non-VLDL TG to Quantify Remnant Lipoprotein Cholesterol (RLP-C): The Very Large Database of Lipids Study 7C | Arteriosclerosis,](https://www.ahajournals.org/cms/asset/98c0a316-4364-4ba5-a79b-1978faeeb87c/g789.jpeg)